Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : RETA crawled time : 11:00 save search
Biogen to Acquire Reata Pharmaceuticals
Published: 2023-07-28 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 51.72%
H: 1.55%
C: 1.52%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.19%
H: 1.88%
C: 0.73%
pharmaceuticals acquire
Reata Pharmaceuticals Announces Three Month Extension of the Review Period for New Drug Application for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Published: 2022-08-09 (Crawled : 11:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -1.21%
H: 0.13%
C: -10.18%
treatment drug extension application review friedreich’s ataxia
Reata Pharmaceuticals, Inc. to Report Second Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on August 8, 2022
Published: 2022-08-01 (Crawled : 11:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: -1.56%
H: 4.98%
C: -1.13%
report update results
Reata Pharmaceuticals Plans NDA Submission for Omaveloxolone in First Quarter of 2022 Following Completion of Pre-NDA Meeting with FDA
Published: 2021-09-30 (Crawled : 11:00) - biospace.com/
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.64%
H: 1.89%
C: -5.08%
fda submission
Reata Announces that The FDA Has Asked The Company to Request a Pre-NDA Meeting for Omaveloxolone for the Treatment of Friedreich’s Ataxia
Published: 2021-05-19 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 13.45%
H: 9.49%
C: 9.11%
treatment fda friedreich's ataxia friedreich’s ataxia
Reata Pharmaceuticals, Inc. Announces First Quarter 2021 Financial Results and Provides an Update on Clinical Development Programs
Published: 2021-05-06 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.68%
H: 2.47%
C: 1.81%
financial results results
Reata Pharmaceuticals Announces Presentations at Upcoming Investor Conferences
Published: 2021-05-03 (Crawled : 11:00) - globenewswire.com
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 0.33%
H: 0.45%
C: -1.55%
presentation conference
Reata Announces the Appointments of Christy J. Oliger and Shamim Ruff to Its Board of Directors
Published: 2021-04-15 (Crawled : 11:00) - globenewswire.com
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.74%
H: 1.86%
C: 1.26%
STOK | $11.64 3.47% 3.35% 1.5M
|
Health Technology
|
| O: 1.66%
H: 0.06%
C: -5.65%
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: 0.61%
H: 2.56%
C: -1.69%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.76%
H: 0.61%
C: 0.14%
RETA | $172.36 0.02% 0.03% 0
|
Health Technology
|
| O: 1.17%
H: 3.5%
C: 1.54%
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.39%
H: 1.37%
C: -5.37%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 1.81%
H: 1.08%
C: 0.18%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.59%
H: 2.35%
C: 1.6%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.